Fundraising FoxAlychlo — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
miDiagnosticsmidiagnostics.cominDec 2024
miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLeuven, BE
Katleen Verleysen(Chief Executive Officer)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.